Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand

View ORCID ProfileMichael J. Plank, Rachelle N. Binny, View ORCID ProfileShaun C. Hendy, Audrey Lustig, View ORCID ProfileAlex James, Nicholas Steyn
doi: https://doi.org/10.1101/2020.04.08.20058743
Michael J. Plank
1School of Mathematics and Statistics University of Canterbury, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Plank
  • For correspondence: michael.plank@canterbury.ac.nz
Rachelle N. Binny
2Manaaki Whenua, Lincoln, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaun C. Hendy
3Department of Physics, University of Auckland, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shaun C. Hendy
Audrey Lustig
2Manaaki Whenua, Lincoln, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex James
1School of Mathematics and Statistics University of Canterbury, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex James
Nicholas Steyn
1School of Mathematics and Statistics University of Canterbury, New Zealand
3Department of Physics, University of Auckland, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

While case numbers remain low, population-wide control methods combined with efficient tracing, testing, and case isolation, offer the opportunity for New Zealand to contain and eliminate COVID-19. We use a stochastic model to investigate containment and elimination scenarios for COVID-19 in New Zealand, as the country considers the exit from its four week period of strong Level 4 population-wide control measures. In particular we consider how the effectiveness of its case isolation operations influence the outcome of lifting these strong population-wide controls. The model is parameterised for New Zealand and is initialised using current case data, although we do not make use of information concerning the geographic dispersion of cases and the model is not stratified for age or co-morbidities.

We find that fast tracing and case isolation (i.e. operations that are sustained at rates comparable to that at the early stages of New Zealand’s response) can lead to containment or elimination, as long as strong population-wide controls remain in place. Slow case isolation can lead to containment (but not elimination) as long as strong Level 4 population-wide controls remain in place. However, we find that relaxing strong population-wide controls after four weeks will most likely lead to a further outbreak, although the speed of growth of this outbreak can be reduced by fast case isolation, by tracing, testing, or otherwise. We find that elimination is only likely if case isolation is combined with strong population-wide controls that are maintained for longer than four weeks.

Further versions of this model will include an age-structured population as well as considering the effects of geographic dispersion and contact network structure, the possibility of regional containment combined with inter-regional travel restrictions, and the potential for harm to at risk communities and essential workers.

Executive Summary

  • While New Zealand case numbers remain low, tracing, testing, and rapid case isolation, combined with population-wide control methods, offer an opportunity for the country to contain and eliminate COVID-19.

  • Simulations using our model suggest that the current population-wide controls (Alert Level 4) have already had a significant effect on new case numbers (see figure below).

    Figure
    • Download figure
    • Open in new tab
  • We also find that fast case isolation, whether as a result of contact tracing, rapid testing, or otherwise, can lead to containment and possibly even elimination, when combined with strong population-wide controls.

  • Slow case isolation can also lead to containment, but only as long as strong population wide controls remain in place. It is unlikely to lead to elimination.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This article does not present new data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand
Michael J. Plank, Rachelle N. Binny, Shaun C. Hendy, Audrey Lustig, Alex James, Nicholas Steyn
medRxiv 2020.04.08.20058743; doi: https://doi.org/10.1101/2020.04.08.20058743
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand
Michael J. Plank, Rachelle N. Binny, Shaun C. Hendy, Audrey Lustig, Alex James, Nicholas Steyn
medRxiv 2020.04.08.20058743; doi: https://doi.org/10.1101/2020.04.08.20058743

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1230)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10005)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2445)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (248)
  • HIV/AIDS (531)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2273)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4824)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (225)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)